Page last updated: 2024-09-05

sorafenib and Blood Loss, Surgical

sorafenib has been researched along with Blood Loss, Surgical in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baba, H; Beppu, T; Chikamoto, A; Hayashi, H; Imai, K; Ishiko, T; Nakamura, K; Nitta, H; Okabe, H; Sasaki, M	1

Other Studies

1 other study(ies) available for sorafenib and Blood Loss, Surgical

Article	Year
Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection. International surgery, 2015, Volume: 100, Issue:5 Topics: Antineoplastic Agents; Biomarkers, Tumor; Blood Loss, Surgical; Carcinoma, Hepatocellular; Combined Modality Therapy; Diagnostic Imaging; Disease-Free Survival; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Operative Time; Phenylurea Compounds; Sorafenib; Thrombosis; Vena Cava, Inferior	2015

Article

Year

Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.

International surgery, 2015, Volume: 100, Issue:5

Topics: Antineoplastic Agents; Biomarkers, Tumor; Blood Loss, Surgical; Carcinoma, Hepatocellular; Combined Modality Therapy; Diagnostic Imaging; Disease-Free Survival; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Operative Time; Phenylurea Compounds; Sorafenib; Thrombosis; Vena Cava, Inferior

2015